Predicting the trajectory of a disease at an early stage can aid physicians in offering effective treatment, prompt care to patients, and also avoid misdiagnosis. However, forecasting patient trajectories is challenging due to long-range dependencies, irregular intervals between consecutive admissions, and non-stationarity data. To address these challenges, we propose a novel method called Clinical-GAN, a Transformer-based Generative Adversarial Networks (GAN) to forecast the patients' medical codes for subsequent visits. First, we represent the patients' medical codes as a time-ordered sequence of tokens akin to language models. Then, a Transformer mechanism is used as a Generator to learn from existing patients' medical history and is trained adversarially against a Transformer-based Discriminator. We address the above mentioned challenges based on our data modeling and Transformer-based GAN architecture. Additionally, we enable the local interpretation of the model's prediction using a multi-head attention mechanism. We evaluated our method using a publicly available dataset, Medical Information Mart for Intensive Care IV v1.0 (MIMIC-IV), with more than 500,000 visits completed by around 196,000 adult patients over an 11-year period from 2008-2019. Clinical-GAN significantly outperforms baseline methods and existing works, as demonstrated through various experiments. Source code is at https://github.com/vigi30/Clinical-GAN.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.artmed.2023.102507 | DOI Listing |
Chimeric antigen receptor (CAR) T-cell products axicabtagene ciloleucel (axi-cel), tisagenlecleucel (tisa-cel), and lisocabtagene maraleucel (liso-cel) are approved for relapsed/refractory large B-cell lymphoma (R/R LBCL). Emerging evidence indicates that delayed CAR T-cell infusion, including prolonged time from leukapheresis to infusion, known as vein-to-vein time (V2Vt), may adversely impact clinical outcomes. We conducted a systematic literature review (SLR) and meta-analysis to identify differences in V2Vt in patients with R/R LBCL treated with axi-cel, tisa-cel, or liso-cel.
View Article and Find Full Text PDFBlood Adv
January 2025
Vanderbilt University Medical Center, Nashville, Tennessee, United States.
In plasma, the zymogens factor XII (FXII) and prekallikrein reciprocally convert each other to the proteases FXIIa and plasma kallikrein (PKa). PKa cleaves high-molecular-weight kininogen (HK) to release bradykinin, which contributes to regulation of blood vessel tone and permeability. Plasma FXII is normally in a "closed" conformation that limits activation by PKa.
View Article and Find Full Text PDFJ Med Internet Res
January 2025
Department High-Tech Business and Entrepreneurship Section, Industrial Engineering and Business Information Systems, University of Twente, Enschede, Overijssel, Netherlands.
Health recommender systems (HRS) have the capability to improve human-centered care and prevention by personalizing content, such as health interventions or health information. HRS, an emerging and developing field, can play a unique role in the digital health field as they can offer relevant recommendations, not only based on what users themselves prefer and may be receptive to, but also using data about wider spheres of influence over human behavior, including peers, families, communities, and societies. We identify and discuss how HRS could play a unique role in decreasing health inequities.
View Article and Find Full Text PDFJMIR Form Res
January 2025
Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Background: Opioid medications are important for pain management, but many patients progress to unsafe medication use. With few personalized and accessible behavioral treatment options to reduce potential opioid-related harm, new and innovative patient-centered approaches are urgently needed to fill this gap.
Objective: This study involved the first phase of co-designing a digital brief intervention to reduce the risk of opioid-related harm by investigating the lived experience of chronic noncancer pain (CNCP) in treatment-seeking patients, with a particular focus on opioid therapy experiences.
JMIR Res Protoc
January 2025
Institute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.
Background: Artificial intelligence (AI)-based clinical decision support systems (CDSS) have been developed for several diseases. However, despite the potential to improve the quality of care and thereby positively impact patient-relevant outcomes, the majority of AI-based CDSS have not been adopted in standard care. Possible reasons for this include barriers in the implementation and a nonuser-oriented development approach, resulting in reduced user acceptance.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!